Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT01819792
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years old with an AML diagnostic and treated with induction and consolidation chemotherapy. Patients enrolled in another protocol may be included.
* Patients with relapsed leukemia who are treated with a salvage intensive therapy stay in the study
* Patients who have signed a consent policyholder
Exclusion Criteria:
* patients under 18 years old
* patients treated with another treatment than induction and consolidation chemotherapy
* pregnant women
* patients HIV, HBV or HBC positive
* patients with a positive PCR at J1
* patients treated with an antiviral treatment or an immunosuppressive treatment for another pathology
* patients under guardianship
* Primitive immunity Deficit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT01819792
Study Brief:
Protocol Section:
NCT01819792